Life Technologies to Redeem Convertible Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market Wednesday that it will redeem all outstanding 3.25 percent convertible senior notes due 2025 on June 15.

The firm said that as of May 6, there was $350 million in aggregate principal amount of the notes outstanding. The notes are convertible prior to June 14, 5:00 p.m. EDT, at a rate of 20.3560 shares of common stock per $1,000 principal amount of the notes surrendered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.